Latest / Off the Chart: A Business of Medicine Podcast
S1 Ep176: Cutting the PBM out of your patient's GLP-1, with Jay Bregman of Andel
GLP-1s broke the traditional pharmacy benefit, and a growing number of employers are responding by buying brand drugs straight from the manufacturer and cutting the insurer and pharmacy benefit manager out of the transaction entirely.
Jay Bregman, founder and CEO of Andel, joins Medical Economics Associate Editor Austin Littrell to explain how the model works from the prescriber's side: the script still starts with the patient's own physician, still travels over Surescripts and still reports back into the chart. What changes is everything after that, including a fixed employer contribution in…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.